During the past decade, University of Miami, Diabetes Research Institute conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 12 clinical trials were completed, i.e. on average, 109.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Miami, Diabetes Research Institute" #1 sponsor was "Rodolfo Alejandro" with 10 trials, followed by "Mannkind Corporation" with 4 trials sponsored, "Halozyme Therapeutics" with 3 trials sponsored, "University of Miami" with 3 trials sponsored and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Miami, Diabetes Research Institute" #1 collaborator was "Diabetes Research Institute Foundation" with 9 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 4 trials as a collaborator, "Health Resources and Services Administration (HRSA)" with 2 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator and "National Institutes of Health (NIH)" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of Miami, Diabetes Research Institute" are "Diabetes Mellitus, Type 1" (11 trials), "Type 1 Diabetes Mellitus" (10 trials), "Diabetes Mellitus" (4 trials), "Type 1 Diabetes" (4 trials) and "Type 2 Diabetes" (4 trials). Many other conditions were trialed in "University of Miami, Diabetes Research Institute" in a lesser frequency.

Most popular intervention types in "University of Miami, Diabetes Research Institute" are "Drug" (22 trials), "Biological" (10 trials), "Other" (9 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Insulin glargine" (4 trials), "Insulin lispro" (3 trials), "Insulin aspart" (2 trials), "Insulin glulisine" (2 trials) and "Islet transplantation" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Miami, Diabetes Research Institute" are 36 trials for "All" genders.

Currently, there are NaN active trials in "University of Miami, Diabetes Research Institute". 1 are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in University of Miami, Diabetes Research Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Miami, Diabetes Research Institute, 10 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".